These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 19468653)
1. Severe irritant contact dermatitis causing skin ulceration secondary to a testosterone patch. Lawrentschuk N; Fleshner N ScientificWorldJournal; 2009 May; 9():333-8. PubMed ID: 19468653 [TBL] [Abstract][Full Text] [Related]
2. Allergic contact dermatitis to testosterone and estrogen in transdermal therapeutic systems. Ta V; Chin WK; White AA Dermatitis; 2014; 25(5):279. PubMed ID: 25207692 [No Abstract] [Full Text] [Related]
3. Transdermal delivery of testosterone. Hadgraft J; Lane ME Eur J Pharm Biopharm; 2015 May; 92():42-8. PubMed ID: 25709060 [TBL] [Abstract][Full Text] [Related]
4. Cutaneous reactions to transdermal therapeutic systems. Musel AL; Warshaw EM Dermatitis; 2006 Sep; 17(3):109-22. PubMed ID: 16956462 [TBL] [Abstract][Full Text] [Related]
5. Allergy and topical irritation associated with transdermal testosterone administration: a comparison of scrotal and nonscrotal transdermal systems. Jordan WP Am J Contact Dermat; 1997 Jun; 8(2):108-13. PubMed ID: 9153333 [TBL] [Abstract][Full Text] [Related]
10. Ulcerative irritant contact dermatitis from lindane. Yu KJ; Chen HH; Chang YC; Hong HS; Ho HC Contact Dermatitis; 2005 Feb; 52(2):118-9. PubMed ID: 15725302 [No Abstract] [Full Text] [Related]
11. Testosterone patches for female sexual dysfunction. Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838 [TBL] [Abstract][Full Text] [Related]
12. Testosterone therapy--what, when and to whom? Jockenhövel F Aging Male; 2004 Dec; 7(4):319-24. PubMed ID: 15799128 [TBL] [Abstract][Full Text] [Related]
13. Contact allergy to testosterone in an androgen patch: control of symptoms by pre-application of topical corticosteroid. Shouls J; Shum KW; Gadour M; Gawkrodger DJ Contact Dermatitis; 2001 Aug; 45(2):124-5. PubMed ID: 11553134 [No Abstract] [Full Text] [Related]
14. Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial. Kühnert B; Byrne M; Simoni M; Köpcke W; Gerss J; Lemmnitz G; Nieschlag E Eur J Endocrinol; 2005 Aug; 153(2):317-26. PubMed ID: 16061839 [TBL] [Abstract][Full Text] [Related]
16. Adhesiveness of a new testosterone-in-adhesive matrix patch after extreme conditions. Raynaud JP; Augès M; Liorzou L; Turlier V; Lauze C Int J Pharm; 2009 Jun; 375(1-2):28-32. PubMed ID: 19481687 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of testosterone gel in the treatment of male hypogonadism. Lakshman KM; Basaria S Clin Interv Aging; 2009; 4():397-412. PubMed ID: 19966909 [TBL] [Abstract][Full Text] [Related]
18. Transfer of topical testosterone preparations to children or spouses. Lewis T; Goldstein I J Sex Med; 2009 Oct; 6(10):2649-52. PubMed ID: 19817980 [No Abstract] [Full Text] [Related]
19. Andropause: is androgen replacement therapy indicated for the aging male? Hijazi RA; Cunningham GR Annu Rev Med; 2005; 56():117-37. PubMed ID: 15660505 [TBL] [Abstract][Full Text] [Related]
20. Ulcerative contact dermatitis caused by benzethonium chloride. Hirata Y; Yanagi T; Yamaguchi Y; Sato K; Shinkuma S; Hata H; Shimizu H Contact Dermatitis; 2017 Mar; 76(3):188-190. PubMed ID: 28220566 [No Abstract] [Full Text] [Related] [Next] [New Search]